Ocaliva 5 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FDQZL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,476
Award facts
- Contract value 100% obligated
- $19,476.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Ocaliva 5 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $19,476.30, was awarded on August 25, 2025, with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement market leveraging its established status and capabilities.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The broader IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support medical supply needs across Department of Defense healthcare facilities worldwide. This arrangement positions DMS Pharmaceutical Group as a key supplier within the federal pharmaceutical supply chain, providing critical distribution services to military health systems.
Quick answers
Who was awarded contract SPE2DB25FDQZL?
SPE2DB25FDQZL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FDQZL worth?
The government has obligated $19,476 on SPE2DB25FDQZL.
Is contract SPE2DB25FDQZL an order under another contract?
Yes. SPE2DB25FDQZL is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQZL competed?
The extent of competition for SPE2DB25FDQZL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award